Domine Gomez, Manuel manuel.domine@uam.es
Actividades
- Artículos 38
- Libros 1
- Capítulos de libro 0
- Congresos 0
- Documentos de trabajo 0
- Informes técnicos 0
- Proyectos de investigación 0
- Tesis dirigidas 0
- Patentes o licencias de software 0
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase II IMPULSE study
- Thomas M, Ponce-Aix S, Navarro A, Riera-Knorrenschild J, Schmidt M, Wiegert E, Kapp K, Wittig B, Mauri C, Dómine Gómez M, Kollmeier J, Sadjadian P, Fröhling KP, Huber RM, Wolf M, IMPULSE study team
Annals Of Oncology (p. 2076-2084) - 1/10/2018
10.1093/annonc/mdy326 Ver en origen
- ISSN 09237534
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program
- J Corral
- Margarita Majem
- Delvys Rodríguez Abreu
- Enric Carcereny Costa
- Ángel Artal Cortés
- M Llorente
- José María López-Picazo González
- Yolanda García García
- Manuel Dómine Gómez
- M P López Criado
Clinical & Translational Oncology (p. 1270-1279) - 1/1/2019
- ISSN 1699048X
- iMarina
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: A phase Ib/randomized phase II trial
- Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, Lowczak A, Aljumaily R, Rocha Lima CM, Boccia RV, Hanna W, Nikolinakos P, Chiu VK, Owonikoko TK, Schuster SR, Hussein MA, Richards DA, Sawrycki P, Bulat I, Hamm JT, Hart LL, Adler S, Antal JM, Lai AY, Sorrentino JA, Yang Z, Malik RK, Morris SR, Roberts PJ, Dragnev KH, G1T28-02 Study Group
Annals Of Oncology (p. 1613-1621) - 1/10/2019
10.1093/annonc/mdz278 Ver en origen
- ISSN 09237534
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
- Levy, B.P.
- Giaccone, G.
- Besse, B.
- Felip, E.
- Garassino, M.C.
- Domine Gomez, M.
- Garrido, P.
- Piperdi, B.
- Ponce-Aix, S.
- Menezes, D.
- MacBeth, K.J.
- Risueño, A.
- Slepetis, R.
- Wu, X.
- Fandi, A.
- Paz-Ares, L.
European Journal Of Cancer (p. 120-128) - 1/2/2019
Editor: Elsevier Ltd
10.1016/j.ejca.2018.11.028 Ver en origen
- ISSN 09598049
- ISSN/ISBN 1879-0852
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
- Dómine Gómez, Manuel
- Morán Bueno, Teresa
- Isla Casado, Dolores
- Martí, J L
- Sullivan, Ivana
- Provencio Pulla, Mariano
- Olmedo García, María Eugenia
- Ponce Aix, Santiago
- Blasco Cordellat, Ana
- Cobo Dols, Manuel
Clinical & Translational Oncology (p. 245-255) - 1/2/2020
10.1007/s12094-020-02295-w Ver en origen
- ISSN 1699048X
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
- Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüro?lu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Ka?arnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L, CASPIAN investigators
Lancet Oncology (p. 51-65) - 1/1/2021
10.1016/s1470-2045(20)30539-8 Ver en origen
- ISSN 14702045
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial
- Laza-Briviesca, Raquel
- Cruz-Bermudez, Alberto
- Nadal, Ernest
- Insa, Amelia
- Garcia-Campelo, Maria del Rosario
- Huidobro, Gerardo
- Domine, Manuel
- Majem, Margarita
- Rodriguez-Abreu, Delvys
- Martinez-Marti, Alex
- De Castro Carpeno, Javier
- Cobo, Manuel
- Lopez Vivanco, Guillermo
- Del Barco, Edel
- Bernabe Caro, Reyes
- Vinolas, Nuria
- Barneto Aranda, Isidoro
- Viteri, Santiago
- Massuti, Bartomeu
- Casarrubios, Marta
- Sierra-Rodero, Belen
- Tarin, Carlos
- Garcia-Grande, Aranzazu
- Haymaker, Cara
- Wistuba, Ignacio I.
- Romero, Atocha
- Franco, Fernando
- Provencio, Mariano;
Clinical And Translational Medicine - 1/7/2021
10.1002/ctm2.491 Ver en origen
- ISSN 20011326
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
- Sanchez-Herrero, Estela
- Serna-Blasco, Roberto
- Ivanchuk, Vadym
- Garcia-Campelo, Rosario
- Gomez, Manuel Domine
- Sanchez, Jose M.
- Massuti, Bartomeu
- Reguart, Noemi
- Camps, Carlos
- Sanz-Moreno, Sandra
- Calabuig-Farinas, Silvia
- Jantus-Lewintre, Eloisa
- Arnal, Magdalena
- Fernandez-Orth, Dietmar
- Calvo, Virginia
- Gonzalez-Rumayor, Victor
- Provencio, Mariano
- Romero, Atocha;
Molecular Oncology (p. 2363-2376) - 1/9/2021
10.1002/1878-0261.13033 Ver en origen
- ISSN 15747891
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
- de la Rosa, CA
- Castellanos, PC
- Lazaro-Quintela, M
- Domine, M
- Estevez, SV
- Lopez-Vivanco, G
- Perez, JLF
- Romero, JLA
- Delgado, LF
- Giron, CG
- Tain, PD
- Alvarez, RA
- Sanchis, PM
- Canton, IF
- Abos, IM
- Aguillo, MM
- Gutierrez, LGA
- Granados, ALO
- Cabellos, RA
- Sebastian, AG
- Sifuentes, LFG
- Reguart, N
Lung Cancer (p. 83-93) - 1/11/2022
10.1016/j.lungcan.2022.09.010 Ver en origen
- ISSN 01695002
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
- Provencio M
- Cobo M
- Rodriguez-Abreu D
- Calvo V
- Carcereny E
- Cantero A
- Bernabé R
- Benitez G
- Castro RL
- Massutí B
- del Barco E
- García Campelo R
- Guirado M
- Camps C
- Ortega AL
- González Larriba JL
- Sánchez A
- Casal J
- Sala MA
- Juan-Vidal O
- Bosch-Barrera J
- Oramas J
- Dómine M
- Trigo JM
- Blanco R
- Calzas J
- Morilla I
- Padilla A
- Pimentao J
- Sousa PA
- Torrente M
Bmc Cancer - 1/12/2022
10.1186/s12885-022-09830-8 Ver en origen
- ISSN 14712407
Este/a investigador/a no tiene capítulos de libro.
Este/a investigador/a no tiene congresos.
Este/a investigador/a no tiene documentos de trabajo.
Este/a investigador/a no tiene informes técnicos.
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene tesis dirigidas.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id